Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

DTIL

Precision BioSciences, Inc.

Healthcare · USD

Set alert

Price alert · DTIL

All alert types
7.06 USD -0.38 -5.11%
As of Oct 30, 2026 Extended hours 7.06 0.00%
Bid
7.05 × 2
Ask
7.08 × 2
6.98 Day range 7.42
3.57 52-week range 9.28
YTD
+69.71%
1 year
-18.00%
Open
7.31
Prev close
7.44
Mkt cap
194.87M
Vol
108.93K
Avg vol
257.87K
EPS
-1.35
P/E
0.00
Div yield
0.00%
More statistics
Low
6.98
High
7.42
Forward P/E
-0.66
Beta
1.69
Short ratio
2.42
Inst. own
44.70%
Dividend
0.00
Ex-div date
Earnings
Aug 1, 2024
50-d avg
7.35
200-d avg
9.90
1y target
33.60

5D chart

Chart tools
Interval
1m5m15m30m
DTIL five-day price chart6.296.677.057.447.82Oct 23Oct 26Oct 28Oct 29

Financial health

Altman Z-Score

-5.20 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -1.2×
FY 2016: -1068×FY 2017: -27.8×FY 2018: -18.6×FY 2019: -7.0×FY 2020: -4.0×FY 2021: -14.2×FY 2022: -0.9×FY 2023: -0.7×FY 2024: 3.6×FY 2025: -1.2×
FY 2016 5y median -0.9× FY 2025
P/S 1.6×
FY 2016: 1248×FY 2017: 90.5×FY 2018: 78.6×FY 2019: 26.2×FY 2020: 17.9×FY 2021: 3.8×FY 2022: 4.2×FY 2023: 0.9×FY 2024: 0.4×FY 2025: 1.6×
FY 2016 5y median 1.6× FY 2025
P/B 0.6×
FY 2016: -1844×FY 2017: -22.3×FY 2018: 21.4×FY 2019: 4.2×FY 2020: 9.8×FY 2021: 4.8×FY 2022: 1.7×FY 2023: 2.2×FY 2024: 0.5×FY 2025: 0.6×
FY 2016 5y median 1.7× FY 2025
P/FCF -0.8×
FY 2016: 97.1×FY 2017: -19.7×FY 2018: -12.7×FY 2019: -5.9×FY 2020: -4.7×FY 2021: -26.1×FY 2022: -2.1×FY 2023: -0.5×FY 2024: -0.4×FY 2025: -0.8×
FY 2016 5y median -0.8× FY 2025
EV/EBITDA 0.7×
FY 2016: -1058×FY 2017: -25.7×FY 2018: -17.2×FY 2019: -4.6×FY 2020: -3.6×FY 2021: -14.8×FY 2022: 1.0×FY 2023: 1.4×FY 2024: -2.2×FY 2025: 0.7×
FY 2016 5y median 0.7× FY 2025
EV/Sales -0.8×
FY 2016: 1235×FY 2017: 80.8×FY 2018: 69.1×FY 2019: 18.1×FY 2020: 14.6×FY 2021: 2.6×FY 2022: -2.4×FY 2023: -0.9×FY 2024: -0.4×FY 2025: -0.8×
FY 2016 5y median -0.8× FY 2025
FCF Yield -123.6%
FY 2016: 1.0%FY 2017: -5.1%FY 2018: -7.9%FY 2019: -16.9%FY 2020: -21.3%FY 2021: -3.8%FY 2022: -46.9%FY 2023: -205.4%FY 2024: -225.5%FY 2025: -123.6%
FY 2016 5y median -123.6% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -152.2%
FY 2016: -125.8%FY 2017: -338.9%FY 2018: -440.2%FY 2019: -392.1%FY 2020: -452.2%FY 2021: -34.1%FY 2022: -248.3%FY 2023: -89.8%FY 2024: -38.1%FY 2025: -152.2%
FY 2016 5y median -89.8% FY 2025
Net Margin -133.4%
FY 2016: -117.6%FY 2017: -325.4%FY 2018: -423.0%FY 2019: -417.6%FY 2020: -448.9%FY 2021: -26.5%FY 2022: -444.8%FY 2023: -125.8%FY 2024: 10.4%FY 2025: -133.4%
FY 2016 5y median -125.8% FY 2025
ROE -49.6%
FY 2016: 173.7%FY 2017: 80.0%FY 2018: -115.2%FY 2019: -67.1%FY 2020: -245.4%FY 2021: -33.6%FY 2022: -184.7%FY 2023: -325.1%FY 2024: 12.7%FY 2025: -49.6%
FY 2016 5y median -49.6% FY 2025
ROIC -35.5%
FY 2016: -9.8%FY 2017: -34.6%FY 2018: -38.5%FY 2019: -41.9%FY 2020: -100.5%FY 2021: -22.2%FY 2022: -34.6%FY 2023: -32.8%FY 2024: -21.3%FY 2025: -35.5%
FY 2016 5y median -32.8% FY 2025
ROA -29.6%
FY 2016: -8.4%FY 2017: -29.0%FY 2018: -33.2%FY 2019: -39.5%FY 2020: -72.6%FY 2021: -14.5%FY 2022: -46.9%FY 2023: -38.4%FY 2024: 5.3%FY 2025: -29.6%
FY 2016 5y median -29.6% FY 2025

Growth (YoY)

Revenue -50.1%
FY 2016: 0.0%FY 2017: -7.6%FY 2018: 67.8%FY 2019: 104.3%FY 2020: 9.2%FY 2021: 375.7%FY 2022: -78.3%FY 2023: 94.1%FY 2024: 41.0%FY 2025: -50.1%
FY 2016 FY 2025
Operating Income -99.3%
FY 2016: 0.0%FY 2017: -148.9%FY 2018: -118.0%FY 2019: -82.0%FY 2020: -25.9%FY 2021: 64.1%FY 2022: -58.2%FY 2023: 29.8%FY 2024: 40.2%FY 2025: -99.3%
FY 2016 FY 2025
EPS (diluted) -442.3%
FY 2016: 0.0%FY 2017: -3738.8%FY 2018: -49.8%FY 2019: -111.2%FY 2020: -5.6%FY 2021: 75.2%FY 2022: -144.2%FY 2023: 58.1%FY 2024: 106.5%FY 2025: -442.3%
FY 2016 FY 2025
Free Cash Flow -12.3%
FY 2016: 0.0%FY 2017: -133.0%FY 2018: -126.7%FY 2019: -45.8%FY 2020: 6.0%FY 2021: 82.0%FY 2022: -194.6%FY 2023: -76.1%FY 2024: 32.1%FY 2025: -12.3%
FY 2016 FY 2025

Financial Health

Current Ratio 13.3×
FY 2016: 11.3×FY 2017: 7.0×FY 2018: 8.2×FY 2019: 7.2×FY 2020: 2.5×FY 2021: 4.5×FY 2022: 3.3×FY 2023: 2.7×FY 2024: 6.3×FY 2025: 13.3×
FY 2016 5y median 4.5× FY 2025
Quick Ratio 13.3×
FY 2016: 11.3×FY 2017: 7.0×FY 2018: 8.2×FY 2019: 7.2×FY 2020: 2.5×FY 2021: 4.5×FY 2022: 3.3×FY 2023: 2.7×FY 2024: 6.3×FY 2025: 13.3×
FY 2016 5y median 4.5× FY 2025
Debt / Equity 0.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.4×FY 2023: 1.7×FY 2024: 0.5×FY 2025: 0.3×
FY 2016 5y median 0.4× FY 2025
Net Debt / EBITDA 1.9×
FY 2016: 11.4×FY 2017: 3.1×FY 2018: 2.4×FY 2019: 2.1×FY 2020: 0.8×FY 2021: 6.6×FY 2022: 2.6×FY 2023: 2.7×FY 2024: -4.1×FY 2025: 1.9×
FY 2016 5y median 2.6× FY 2025
Interest Coverage -36.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -479×FY 2020: 0.0×FY 2021: -298×FY 2022: -56.1×FY 2023: -19.6×FY 2024: -14.7×FY 2025: -36.7×
FY 2016 5y median -36.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31